{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T05:14:52Z","timestamp":1791954892113,"version":"4.3.4"},"reference-count":79,"publisher":"American Medical Association (AMA)","issue":"21","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA"],"published-print":{"date-parts":[[2022,6,7]]},"DOI":"10.1001\/jama.2022.6381","type":"journal-article","created":{"date-parts":[[2022,5,24]],"date-time":"2022-05-24T15:09:17Z","timestamp":1653404957000},"page":"2129","source":"Crossref","is-referenced-by-count":33,"title":["Screening for Impaired Visual Acuity in Older Adults"],"prefix":"10.1001","volume":"327","author":[{"given":"Roger","family":"Chou","sequence":"first","affiliation":[{"name":"Pacific Northwest Evidence-based Practice Center, Department of Medical Informatics and Clinical Epidemiology, Oregon Health & Science University, Portland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Bougatsos","sequence":"additional","affiliation":[{"name":"Pacific Northwest Evidence-based Practice Center, Department of Medical Informatics and Clinical Epidemiology, Oregon Health & Science University, Portland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Jungbauer","sequence":"additional","affiliation":[{"name":"Pacific Northwest Evidence-based Practice Center, Department of Medical Informatics and Clinical Epidemiology, Oregon Health & Science University, Portland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Grusing","sequence":"additional","affiliation":[{"name":"Pacific Northwest Evidence-based Practice Center, Department of Medical Informatics and Clinical Epidemiology, Oregon Health & Science University, Portland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Blazina","sequence":"additional","affiliation":[{"name":"Pacific Northwest Evidence-based Practice Center, Department of Medical Informatics and Clinical Epidemiology, Oregon Health & Science University, Portland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shelley","family":"Selph","sequence":"additional","affiliation":[{"name":"Pacific Northwest Evidence-based Practice Center, Department of Medical Informatics and Clinical Epidemiology, Oregon Health & Science University, Portland"},{"name":"Department of Family Medicine, Oregon Health & Science University; Portland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel E.","family":"Jonas","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, The Ohio State University, Columbus"},{"name":"RTI International, University of North Carolina at Chapel Hill Evidence-based Practice Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shandiz","family":"Tehrani","sequence":"additional","affiliation":[{"name":"Casey Eye Institute, Department of Ophthalmology, Oregon Health & Science University; Portland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"5","key":"jus220010r1","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1001\/jamaophthalmol.2020.0273","article-title":"Eye care among US adults at high risk for vision loss in the United States in 2002 and 2017.","volume":"138","author":"Saydah","year":"2020","journal-title":"JAMA Ophthalmol"},{"issue":"4","key":"jus220010r3","doi-asserted-by":"publisher","first-page":"e385","DOI":"10.1016\/S2214-109X(21)00031-0","article-title":"Ageing and vision loss: looking to the future.","volume":"9","author":"Swenor","year":"2021","journal-title":"Lancet Glob Health"},{"issue":"9","key":"jus220010r4","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1001\/jama.2016.0763","article-title":"Screening for impaired visual acuity in older adults: US Preventive Services Task Force recommendation statement.","volume":"315","author":"US Preventive Services Task Force","year":"2016","journal-title":"JAMA"},{"issue":"9","key":"jus220010r5","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1001\/jama.2016.0783","article-title":"Screening for impaired visual acuity in older adults: updated evidence report and systematic review for the US Preventive Services Task Force.","volume":"315","author":"Chou","year":"2016","journal-title":"JAMA"},{"issue":"1","key":"jus220010r9","doi-asserted-by":"publisher","first-page":"44","DOI":"10.7326\/0003-4819-151-1-200907070-00008","article-title":"Screening older adults for impaired visual acuity: a review of the evidence for the US Preventive Services Task Force.","volume":"151","author":"Chou","year":"2009","journal-title":"Ann Intern Med"},{"issue":"7","key":"jus220010r10","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000254.pub4","article-title":"Antioxidant vitamin and mineral supplements for slowing the progression of age-related macular degeneration.","volume":"7","author":"Evans","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"jus220010r11","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000254.pub3","article-title":"Antioxidant vitamin and mineral supplements for slowing the progression of age-related macular degeneration.","volume":"11","author":"Evans","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"issue":"5","key":"jus220010r12","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1016\/S0161-6420(00)00649-7","article-title":"Sensitivity and specificity of tests to detect eye disease in an older population.","volume":"108","author":"Ivers","year":"2001","journal-title":"Ophthalmology"},{"issue":"9","key":"jus220010r13","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1212\/01.WNL.0000142969.19465.8F","article-title":"Impact of antioxidants, zinc, and copper on cognition in the elderly: a randomized, controlled trial.","volume":"63","author":"Yaffe","year":"2004","journal-title":"Neurology"},{"issue":"12","key":"jus220010r14","doi-asserted-by":"publisher","first-page":"2318","DOI":"10.1016\/S0161-6420(98)91235-0","article-title":"Screening for ophthalmic disease in older subjects using visual acuity and contrast sensitivity.","volume":"105","author":"Woods","year":"1998","journal-title":"Ophthalmology"},{"issue":"11","key":"jus220010r15","doi-asserted-by":"publisher","first-page":"8174","DOI":"10.1167\/iovs.11-7522","article-title":"Effects of lutein supplementation on macular pigment optical density and visual acuity in patients with age-related macular degeneration.","volume":"52","author":"Weigert","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"jus220010r16","first-page":"1290","article-title":"Effects of zinc and antioxidant on visual function of patients with age-related macular degeneration.","volume":"8","author":"Wang","year":"2004","journal-title":"Zhongguo Linchuang Kangfu"},{"issue":"7","key":"jus220010r17","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1016\/j.ophtha.2016.03.037","article-title":"Morphology and visual acuity in aflibercept and ranibizumab therapy for neovascular age-related macular degeneration in the VIEW trials.","volume":"123","author":"Waldstein","year":"2016","journal-title":"Ophthalmology"},{"issue":"7354","key":"jus220010r18","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1136\/bmj.325.7354.11","article-title":"Vitamin E supplementation and macular degeneration: randomised controlled trial.","volume":"325","author":"Taylor","year":"2002","journal-title":"BMJ"},{"issue":"2","key":"jus220010r19","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1111\/ceo.2006.34.issue-2","article-title":"Eye care service utilization in older people seeking aged care.","volume":"34","author":"Tay","year":"2006","journal-title":"Clin Exp Ophthalmol"},{"issue":"3","key":"jus220010r20","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1620\/tjem.240.209","article-title":"a-Lipoic acid treatment improves vision-related quality of life in patients with dry age-related macular degeneration.","volume":"240","author":"Tao","year":"2016","journal-title":"Tohoku J Exp Med"},{"issue":"3","key":"jus220010r21","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1111\/(ISSN)1532-5415","article-title":"The nursing home minimum data set for vision and its association with visual acuity and contrast sensitivity.","volume":"57","author":"Swanson","year":"2009","journal-title":"J Am Geriatr Soc"},{"issue":"7","key":"jus220010r22","first-page":"1225","article-title":"Oral zinc and the second eye in age-related macular degeneration.","volume":"37","author":"Stur","year":"1996","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"7422","key":"jus220010r23","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1136\/bmj.327.7422.1027","article-title":"Screening older people for impaired vision in primary care: cluster randomised trial.","volume":"327","author":"Smeeth","year":"2003","journal-title":"BMJ"},{"issue":"14","key":"jus220010r24","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1056\/NEJMoa054481","article-title":"Ranibizumab for neovascular age-related macular degeneration.","volume":"355","author":"Rosenfeld","year":"2006","journal-title":"N Engl J Med"},{"issue":"4","key":"jus220010r25","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/S1529-1839(04)70049-4","article-title":"Double-masked, placebo-controlled, randomized trial of lutein and antioxidant supplementation in the intervention of atrophic age-related macular degeneration: the Veterans LAST study (Lutein Antioxidant Supplementation Trial).","volume":"75","author":"Richer","year":"2004","journal-title":"Optometry"},{"issue":"1","key":"jus220010r26","first-page":"30","article-title":"Multicenter ophthalmic and nutritional age-related macular degeneration study\u2014part 2: antioxidant intervention and conclusions.","volume":"67","author":"Richer","year":"1996","journal-title":"J Am Optom Assoc"},{"issue":"2","key":"jus220010r27","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.ajo.2007.10.004","article-title":"Randomized, double-masked, sham-controlled trial of ranibizumab for neovascular age-related macular degeneration: PIER Study year 1.","volume":"145","author":"Regillo","year":"2008","journal-title":"Am J Ophthalmol"},{"issue":"2","key":"jus220010r28","doi-asserted-by":"publisher","first-page":"216","DOI":"10.5301\/ejo.5000069","article-title":"Carotenoids in Age-related Maculopathy Italian Study (CARMIS): two-year results of a randomized study.","volume":"22","author":"Piermarocchi","year":"2012","journal-title":"Eur J Ophthalmol"},{"issue":"2","key":"jus220010r29","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1177\/1120672119836007","article-title":"Effect of 2-year nutritional supplementation on progression of age-related macular degeneration.","volume":"30","author":"Piatti","year":"2020","journal-title":"Eur J Ophthalmol"},{"issue":"2","key":"jus220010r30","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1001\/archopht.1988.01060130202026","article-title":"Oral zinc in macular degeneration.","volume":"106","author":"Newsome","year":"1988","journal-title":"Arch Ophthalmol"},{"issue":"7","key":"jus220010r31","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1080\/02713680802178437","article-title":"A randomized, prospective, placebo-controlled clinical trial of a novel zinc-monocysteine compound in age-related macular degeneration.","volume":"33","author":"Newsome","year":"2008","journal-title":"Curr Eye Res"},{"issue":"3","key":"jus220010r32","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1167\/iovs.12-10715","article-title":"Lutein supplementation over a one-year period in early AMD might have a mild beneficial effect on visual acuity: the CLEAR study.","volume":"54","author":"Murray","year":"2013","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"jus220010r33","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s12877-018-0761-z","article-title":"Performance of a brief geriatric evaluation compared to a comprehensive geriatric assessment for detection of geriatric syndromes in family medicine: a prospective diagnostic study.","volume":"18","author":"Mueller","year":"2018","journal-title":"BMC Geriatr"},{"issue":"4","key":"jus220010r34","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/S0002-9343(97)00089-2","article-title":"A randomized trial of office-based screening for common problems in older persons.","volume":"102","author":"Moore","year":"1997","journal-title":"Am J Med"},{"issue":"6","key":"jus220010r35","first-page":"327","article-title":"The detection of visual disability in the elderly.","volume":"46","author":"McMurdo","year":"1988","journal-title":"Health Bull (Edinb)"},{"issue":"11","key":"jus220010r36","doi-asserted-by":"publisher","first-page":"2290","DOI":"10.1016\/j.ophtha.2012.06.014","article-title":"Effect of lutein and zeaxanthin on macular pigment and visual function in patients with early age-related macular degeneration.","volume":"119","author":"Ma","year":"2012","journal-title":"Ophthalmology"},{"issue":"6","key":"jus220010r37","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1159\/000310646","article-title":"Visaline in the treatment of age-related macular degeneration: a pilot study.","volume":"209","author":"Kaiser","year":"1995","journal-title":"Ophthalmologica"},{"issue":"2","key":"jus220010r38","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/j.juro.2006.09.047","article-title":"High dose zinc increases hospital admissions due to genitourinary complications.","volume":"177","author":"Johnson","year":"2007","journal-title":"J Urol"},{"issue":"4","key":"jus220010r39","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1111\/j.1475-1313.2012.00919.x","article-title":"The development & evaluation of two vision screening tools for correctable visual loss in older people.","volume":"32","author":"Jessa","year":"2012","journal-title":"Ophthalmic Physiol Opt"},{"key":"jus220010r40","first-page":"391","article-title":"Oral zinc-therapy in age-related macular degeneration: a double blind study.","volume":"2","author":"Holz","year":"1993","journal-title":"Ger J Ophthalmol"},{"issue":"7","key":"jus220010r41","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1016\/j.oret.2017.10.017","article-title":"Impact of baseline characteristics on treatment response to intravitreal aflibercept injection for wet age-related macular degeneration.","volume":"2","author":"Ho","year":"2018","journal-title":"Ophthalmol Retina"},{"issue":"1","key":"jus220010r42","doi-asserted-by":"publisher","first-page":"93","DOI":"10.2105\/AJPH.73.1.93","article-title":"Validity of a survey question as a measure of visual acuity impairment.","volume":"73","author":"Hiller","year":"1983","journal-title":"Am J Public Health"},{"issue":"12","key":"jus220010r43","doi-asserted-by":"publisher","first-page":"2537","DOI":"10.1016\/j.ophtha.2012.09.006","article-title":"Intravitreal aflibercept (VEGF trap-eye) in wet age-related macular degeneration.","volume":"119","author":"Heier","year":"2012","journal-title":"Ophthalmology"},{"issue":"27","key":"jus220010r44","doi-asserted-by":"publisher","first-page":"2805","DOI":"10.1056\/NEJMoa042760","article-title":"Pegaptanib for neovascular age-related macular degeneration.","volume":"351","author":"Gragoudas","year":"2004","journal-title":"N Engl J Med"},{"issue":"4","key":"jus220010r45","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1001\/jamaophthalmol.2018.6776","article-title":"Effect of ranibizumab and aflibercept on best-corrected visual acuity in treat-and-extend for neovascular age-related macular degeneration: a randomized clinical trial.","volume":"137","author":"Gillies","year":"2019","journal-title":"JAMA Ophthalmol"},{"issue":"4","key":"jus220010r46","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1080\/028134300448751","article-title":"Screening for hearing and visual loss among elderly with questionnaires and tests: which method is the most convincing for action?","volume":"18","author":"Eekhof","year":"2000","journal-title":"Scand J Prim Health Care"},{"issue":"4","key":"jus220010r47","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1093\/fampra\/17.4.329","article-title":"Effects of screening for disorders among the elderly: an intervention study in general practice.","volume":"17","author":"Eekhof","year":"2000","journal-title":"Fam Pract"},{"issue":"2","key":"jus220010r48","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.ophtha.2008.09.019","article-title":"Risk of advanced age-related macular degeneration after cataract surgery in the Age-Related Eye Disease Study: AREDS report 25.","volume":"116","author":"Chew","year":"2009","journal-title":"Ophthalmology"},{"issue":"8","key":"jus220010r49","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1016\/j.ophtha.2013.01.021","article-title":"Long-term effects of vitamins C and E, \u00df-carotene, and zinc on age-related macular degeneration: AREDS report no. 35.","volume":"120","author":"Chew","year":"2013","journal-title":"Ophthalmology"},{"issue":"8","key":"jus220010r50","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1001\/jama.2015.9677","article-title":"Effect of omega-3 fatty acids, lutein\/zeaxanthin, or other nutrient supplementation on cognitive function: the AREDS2 randomized clinical trial.","volume":"314","author":"Chew","year":"2015","journal-title":"JAMA"},{"issue":"11","key":"jus220010r51","doi-asserted-by":"publisher","first-page":"2282","DOI":"10.1016\/j.ophtha.2012.05.027","article-title":"The Age-Related Eye Disease Study 2 (AREDS2): study design and baseline characteristics (AREDS2 report number 1).","volume":"119","author":"Chew","year":"2012","journal-title":"Ophthalmology"},{"issue":"11","key":"jus220010r52","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1001\/archopht.125.11.1460","article-title":"Improved vision-related function after ranibizumab treatment of neovascular age-related macular degeneration: results of a randomized clinical trial.","volume":"125","author":"Chang","year":"2007","journal-title":"Arch Ophthalmol"},{"issue":"1","key":"jus220010r53","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.ophtha.2012.07.027","article-title":"Driving ability reported by neovascular age-related macular degeneration patients after treatment with ranibizumab.","volume":"120","author":"Bressler","year":"2013","journal-title":"Ophthalmology"},{"issue":"11","key":"jus220010r54","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1017\/S0007114512004187","article-title":"The effects of a lutein-based supplement on objective and subjective measures of retinal and visual function in eyes with age-related maculopathy\u2014a randomised controlled trial.","volume":"109","author":"Berrow","year":"2013","journal-title":"Br J Nutr"},{"issue":"3","key":"jus220010r55","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1016\/j.ophtha.2012.08.040","article-title":"Secondary outcomes in a clinical trial of carotenoids with coantioxidants versus placebo in early age-related macular degeneration.","volume":"120","author":"Beatty","year":"2013","journal-title":"Ophthalmology"},{"issue":"9","key":"jus220010r56","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1038\/sj.ejcn.1602626","article-title":"Effect of lutein and antioxidant dietary supplementation on contrast sensitivity in age-related macular disease: a randomized controlled trial.","volume":"61","author":"Bartlett","year":"2007","journal-title":"Eur J Clin Nutr"},{"issue":"6","key":"jus220010r57","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1016\/j.ajo.2014.02.031","article-title":"Assessment of a rapid method to determine approximate visual acuity in large surveys and other such settings.","volume":"157","author":"Arora","year":"2014","journal-title":"Am J Ophthalmol"},{"issue":"11","key":"jus220010r58","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1016\/S0161-6420(96)30431-4","article-title":"Sensitivity, specificity, and predictive values of screening tests for eye conditions in a clinic-based population.","volume":"103","author":"Ariyasu","year":"1996","journal-title":"Ophthalmology"},{"issue":"10","key":"jus220010r59","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1001\/archopht.119.10.1417","article-title":"A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8.","volume":"119","author":"Age-Related Eye Disease Study Research Group","year":"2001","journal-title":"Arch Ophthalmol"},{"issue":"19","key":"jus220010r60","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1001\/jama.2013.4997","article-title":"Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial.","volume":"309","author":"Age-Related Eye Disease Study 2 Research Group","year":"2013","journal-title":"JAMA"},{"issue":"5","key":"jus220010r61","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1080\/09286580490888807","article-title":"Incorporating vision and hearing tests into aged care assessment: methods and the pilot study.","volume":"11","author":"Jee","year":"2004","journal-title":"Ophthalmic Epidemiol"},{"issue":"2","key":"jus220010r62","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.ophtha.2019.08.023","article-title":"Macular atrophy in neovascular age-related macular degeneration: a randomized clinical trial comparing ranibizumab and aflibercept (RIVAL study).","volume":"127","author":"Gillies","year":"2020","journal-title":"Ophthalmology"},{"issue":"7","key":"jus220010r63","first-page":"1360","article-title":"Responsiveness and the minimal clinically important difference for the NEI VFQ-25 in patients with macular telangectasia type 2 (MacTel Type 2).","volume":"56","author":"Clemons","year":"2015","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"jus220010r64","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1001\/jamaophthalmol.2013.6636","article-title":"Ten-year follow-up of age-related macular degeneration in the age-related eye disease study: AREDS report no. 36.","volume":"132","author":"Chew","year":"2014","journal-title":"JAMA Ophthalmol"},{"issue":"564738","key":"jus220010r65","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/564738","article-title":"Effect of supplemental lutein and zeaxanthin on serum, macular pigmentation, and visual performance in patients with early age-related macular degeneration.","volume":"2015","author":"Huang","year":"2015","journal-title":"Biomed Res Int"},{"issue":"6","key":"jus220010r66","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1016\/j.ophtha.2006.02.027","article-title":"Pegaptanib sodium for neovascular age-related macular degeneration: two-year safety results of the two prospective, multicenter, controlled clinical trials.","volume":"113","author":"D\u2019Amico","year":"2006","journal-title":"Ophthalmology"},{"key":"jus220010r67","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001054.pub3","article-title":"Community screening for visual impairment in older people.","volume":"2","author":"Clarke","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"issue":"6141","key":"jus220010r69","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1136\/bmj.2.6141.859","article-title":"Screening for impaired visual acuity in middle age in general practice.","volume":"2","author":"Stone","year":"1978","journal-title":"Br Med J"},{"issue":"2","key":"jus220010r70","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1111\/jgs.2006.54.issue-2","article-title":"Utility of a patient-response screening question for visual impairment.","volume":"54","author":"Chu-Ai Teh","year":"2006","journal-title":"J Am Geriatr Soc"},{"issue":"2","key":"jus220010r71","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1076\/opep.5.2.69.1575","article-title":"Evaluation of screening schemes for eye disease in a primary care setting.","volume":"5","author":"Wang","year":"1998","journal-title":"Ophthalmic Epidemiol"},{"issue":"1","key":"jus220010r73","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000253.pub2","article-title":"Antioxidant vitamin and mineral supplements for preventing age-related macular degeneration.","author":"Evans","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"jus220010r74","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1002\/cncr.v113:1","article-title":"Beta-carotene in multivitamins and the possible risk of lung cancer among smokers versus former smokers: a meta-analysis and evaluation of national brands.","volume":"113","author":"Tanvetyanon","year":"2008","journal-title":"Cancer"},{"issue":"10","key":"jus220010r76","doi-asserted-by":"publisher","first-page":"2225","DOI":"10.1016\/j.ophtha.2016.06.053","article-title":"Introducing anti-vascular endothelial growth factor therapies for AMD did not raise risk of myocardial infarction, stroke, and death.","volume":"123","author":"Yashkin","year":"2016","journal-title":"Ophthalmology"},{"issue":"210","key":"jus220010r77","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.ajo.2019.10.007","article-title":"Ten-year treatment outcomes of neovascular age-related macular degeneration from two regions.","volume":"210","author":"Gillies","year":"2020","journal-title":"Am J Ophthalmol"},{"issue":"10","key":"jus220010r79","doi-asserted-by":"publisher","first-page":"776","DOI":"10.7326\/0003-4819-148-10-200805200-00010","article-title":"Using existing systematic reviews in complex systematic reviews.","volume":"148","author":"Whitlock","year":"2008","journal-title":"Ann Intern Med"},{"key":"jus220010r6","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2016.0783","volume-title":"Screening for Impaired Visual Acuity in Older Adults: A Systematic Review to Update the 2009 US Preventive Services Task Force Recommendation","author":"Chou","year":"2016"},{"key":"jus220010r7","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2022.6381","volume-title":"Screening for Impaired Visual Acuity in Older Adults: A Systematic Review for the US Preventive Services Task Force. Evidence Synthesis No. 213","author":"Chou","year":"2022"},{"key":"jus220010r72","volume-title":"Screening for Visual Impairment in Older Adults: Systematic Review to Update the 1996 US Preventive Services Task Force Recommendation. Evidence Synthesis No. 71","author":"Chou","year":"2009"},{"key":"jus220010r2","unstructured":"American Foundation for the Blind. Aging and vision loss fact sheet. Published 2013. Accessed October 15, 2014. https:\/\/www.afb.org\/info\/programs-and-services\/professional-development\/experts-guide\/aging-and-vision-loss\/1235"},{"key":"jus220010r8","unstructured":"US Preventive Services Task Force. US Preventive Services Task Force Procedure Manual. Published 2018. Accessed September 16, 2020. https:\/\/www.uspreventiveservicestaskforce.org\/uspstf\/procedure-manual"},{"key":"jus220010r68","unstructured":"Pillay? J, Freeman? EE, Hodge? W, . Screening for impaired visual acuity and vision-related functional limitations in adults 65 years and older in primary health care: systematic review. Published 2017. Accessed May 8, 2020. https:\/\/canadiantaskforce.ca\/ctfphc-guidelines\/overview\/"},{"key":"jus220010r75","unstructured":"National Eye Institute. AREDS\/AREDS2 clinical trials. Published 2020. Accessed September 5, 2020. https:\/\/www.nei.nih.gov\/research\/clinical-trials\/age-related-eye-disease-studies-aredsareds2\/about-areds-and-areds2"},{"key":"jus220010r78","unstructured":"Beovu\u2019s future: reasons for uncertainty and hope. Review of Ophthalmology. Published July 15, 2021. Accessed November 6, 2021. https:\/\/reviewofophthalmology.com\/article\/beovus-future-reasons-for-uncertainty-and-hope"}],"container-title":["JAMA"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/articlepdf\/2792706\/jama_chou_2022_us_220010_1659622372.80154.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,9]],"date-time":"2022-08-09T15:03:15Z","timestamp":1660057395000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/fullarticle\/2792706"}},"subtitle":["Updated Evidence Report and Systematic Review for the US Preventive Services Task Force"],"short-title":[],"issued":{"date-parts":[[2022,6,7]]},"references-count":79,"journal-issue":{"issue":"21","published-print":{"date-parts":[[2022,6,7]]}},"URL":"https:\/\/doi.org\/10.1001\/jama.2022.6381","relation":{},"ISSN":["0098-7484"],"issn-type":[{"value":"0098-7484","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6,7]]}}}